CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Phase I study of sunitinib in combination with gemcitabine/capecitabine for the first-line treatment of metastatic or unresectable renal cell carcinoma.
Author
C. Suarez
E. Gallardo
+10 more
F. Pons
I. Moya
J. Albanell
J. Bellmunt
J. Carles
J. Rodon Ahnert
M. Beltran
M. Guix
S. Galtes
T. Bonfill
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase I study of high-dose bi-weekly gemcitabine at a constant rate infusion (CRI) without growth factor support in advanced solid tumors, including prior standard gemcitabine treated patients
Author
A. Perez-Romero
E. Alba
+8 more
I. Garcia-Ribas
J. Baselga
J. Bellmunt
J. J. de la Cruz
J. M. Roca
J. M. Tabernero
J. M. Trigo
S. Galtes
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Variations in the anatomy of the vertebral artery cervical loop segment - a potential predisposing factor for traumatic basal subarachnoid hemorrhage?
Author
A Bromilow
A Gross
+32 more
AM Farag
Azzam Taktak
B Knight
B Koszyca
B Wong
C. Paul Johnson
CP Johnson
CP Johnson
DL Contostavlos
DL Contostavlos
F Cacciola
GC Coast
HL Whitwell
I Galtes
IM Wilkinson
J Simonsen
JH Deck
JL Dumas
JM Cameron
Jonathan E. Medcalf
JT Gray
K Opeskin
MJ Pickup
O Wiseman
P Vanezis
S Grabherr
S Grabherr
S Grabherr
S Grabherr
S Kim
S Leadbeatter
Silke Grabherr
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref